Pfizer Inc.
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
Last updated:
Abstract:
The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.
Status:
Grant
Type:
Utility
Filling date:
24 May 2018
Issue date:
23 Mar 2021